Mandate

Vinge advises on the sale of Bygghemma Group

November 14, 2014

Vinge has advised the sellers, which included Patrick Hannell and Pelle Törnberg, in connection with the sale of Bygghemma Intressenter AB to Nordstjernan Investment AB. Bygghemma is the Nordic region’s leading e-commerce company offering home improvement and home furnishing products. During the last few years, Bygghemma has demonstrated substantial growth and this year’s turnover will be approximately SEK 1.3 billion. Nordstjernan is an investment company controlled by the Ax:son Johnson family. Bygghemma’s management will remain as owners.

Vinge’s team consisted of Kristian Ford together with, among others, Henrik Jonsson and Fredrik Christiansson.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026